Close
ACHEMA MIDDLE EAST 2026
LogiPharma 2026

Drug Development

      Global Biopharma Market to Hit $566B by 2032

      Americas
      Global Biopharma Market Forecasts $566B By 2032 opposing Challenges With a compound annual growth rate of almost 8%, from $263 billion in 2022 to $566...

      AI Boosts Small Molecule Therapies for I&I Diseases

      Articles
      Drug development which happens to be powered by AI, is going ahead and countering incentives from the Inflation Reduction Act and also making the...

      Celonic Group Signs Long-Term Multi-Year Manufacturing Service Agreement with LINDIS Biotech for the Commercial Supply of Catumaxomab

      Drug Development
      LINDIS Biotech has received an EMA Marketing Authorization for catumaxomab, making it the only drug approved for the specific and cancer-directed treatment of...

      Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront

      Americas
      Anthos Therapeutics is a clinical-stage biopharmaceutical company developing abelacimab, a potential first-in-class monoclonal antibody targeting the FXI inhibition pathway Abelacimab is currently in...

      Bio-Rad to Acquire Stilla Technologies by Q3 2025

      Clinical Trials
      Bio-Rad Laboratories to Acquire Stilla Technologies to Expand Digital PCR Portfolio Stilla Technologies to Be Acquired by Bio-Rad Laboratories to Increase Digital PCR Portfolio A binding...

      New Method of Drug Value: Incorporating Real-World Data

      Drug Development
      Determining the value of a medicine may be a challenging task. To put it another way, how much is the value of a patient’s...

      AI And The Future of Drug Discovery And Manufacturing

      Drug Development
      Artificial Intelligence (AI) is transforming the pharmaceutical industry, driving significant advancements across various stages of drug discovery, development, and production. By leveraging AI technologies,...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

      System

      Resources

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.